Infinity Pharmaceuticals Soared on New Cancer Drug @tradethetrend142
Infinity Pharmaceuticals Soared on New Cancer Drug  @tradethetrend142
Uploaded December 2012 | Updated November 2026, 2 hours ago
Infinity Pharmaceuticals (NASDAQ:INFI) popular in today's session after shares of the company surged to their highest level in a decade yesterday. The company announced positive results from its clinical trial of its drug IPI-145, a treatment for blood cancers. This caused it's stock to increase 21.4 percent to $27.35, close to the day's peak of $27.60.

The study on this new drug is not over and is still not approved for sale yet. But, Infinity says it was active against advanced blood cancers like chronic lymphocytic leukemia and Hodgkin's lymphoma, making it a very desirable drug.

Infinity Pharmaceuticals could continue to rise in today's session. Premarket, its stock was up just a half a percent.
Infinity Pharmaceuticals Soared on New Cancer DrugSmarTrend Market Close Wrap-Up   October 31, 2011SmarTrend Market Close Wrap-Up   October 11, 2011 (DJI,INX,IXIC)Michael Jacksons ER Doctor Back On stand in Conrad Murray Trial for Week 2SmarTrend Market Close Wrap-Up   December 13, 2011 (DJI,INX,IXIC)SmarTrend Market Close Wrap-Up   November 7, 2011SmarTrend Market Close Wrap-Up   September 23, 2011Canada Sees Unemployment Rate Increase in SeptemberSmarTrend Market Close Wrap-Up   August 30, 2011SmarTrend Market Close Wrap-Up   July 7, 2011SmarTrend Market Close Wrap-Up   September 26, 2011Citigroup Beats the Street on Third Quater Earnings
TradeTheTrend |

Infinity Pharmaceuticals Soared on New Cancer Drug

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER